ATS 2019 Virtual Final Program

CLINICAL POSTGRADUATE COURSE CME Credits Available: 6.5 PG15 A CLINICIAN’S GUIDE TO LUNG TRANSPLANTATION R Pre-registration and additional fees required. Continental breakfast and box lunch included. Attendance is limited. Member: $350 In-Training Member: $200 Non-Member: $425 In-Training Non-Member: $300 : Registrants must bring a laptop to the course to view the course material. Assemblies on Clinical Problems; Allergy, Immunology and Inflammation; Pulmonary Infections and Tuberculosis 8:00 a.m. - 4:00 p.m. KBHCCD Room D162/D164 (Level 1) Target Audience Providers who care for patients who have had or may require lung transplantation, this includes transplant and non-transplant focused professionals;providers who are not at a transplant center but who care for patients before and after transplant Objectives At the conclusion of this session, the participant will be able to: • more appropriately refer potential candidates for lung transplantation; • become familiar with the short and long-term outcomes,as well as care and management of lung transplant recipients; • become familiar with current efforts to increase organ donation and utilization. This session will be a comprehensive review of lung transplantation covering: candidate selection; organ donation and allocation; immunosuppressive medications and management; long and short term outcomes; infections; and pulmonary and non-pulmonary complications. It will include review lectures; case-based presentations; and panel discussions. The goal is to provide a broad foundation for learners seeking greater familiarity and enhanced expertise in this area. Chairing: J.D. Edelman, MD, Seattle, WA S.M. Bhorade, MD, Chicago, IL A.R. Glanville, MD, MBBS, Sydney, Australia J. Gottlieb, MD, Hannover, Germany 8:00 Introduction J.D. Edelman, MD, Seattle, WA 8:15 Guidelines for Lung Transplant Referral and Selection A.R. Glanville, MD, MBBS, Sydney, Australia 8:50 Lung Donation and Allocation (US) E.D. Lease, MD, Seattle, WA 9:10 Lung Donation and Allocation (Europe) J. Gottlieb, MD, Hannover, Germany 9:30 Organ Donation and Allocation Panel Discussion 9:40 Organ Procurement and Preservation P. Sanchez, MD,PhD, Pittsburgh, PA 10:10 Break 10:25 Pushing the Candidate Envelope R.M. Kotloff, MD, Cleveland, OH 10:55 Ethical Paradigms and Challenges in Lung Transplantation E.R. Garrity, MD, MBA, Chicago, IL 11:25 Disease Specific Implications Before and After Transplant S. Kapnadak, MD, Seattle, WA 11:55 LUNCH 12:45 Pediatric Lung Transplantation S.C. Sweet, MD, PhD, St. Louis, MO 1:10 Immunosuppression: State of the Art S.M. Bhorade, MD, Chicago, IL 1:35 Infections in Lung Transplant Recipient S. Husain, MD, MS, Toronto, Canada 2:00 Cellular Rejection, Humoral Rejection, Allo- and Auto-Antibodies D.J. Levine, MD, San Antonio, TX 2:30 Break 2:45 Complications: Chronic Lung Allograft Dysfunction J.D. Edelman, MD, Seattle, WA 3:10 Quality of Life and Functional Status Before and After Lung Transplantation B.M. Hoffman, PhD, Durham, NC 3:35 Medical Challenges Faced by Lung Transplant Recipients J.D. Edelman, MD, Seattle, WA CLINICAL POSTGRADUATE COURSE CME Credits Available: 7 PG16 INTERSTITIAL LUNG DISEASE: DELIVERING OPTIMAL, PATIENT CENTERED CARE R Pre-registration and additional fees required. Continental breakfast and box lunch included. Attendance is limited. Member: $350 In-Training Member: $200 Non-Member: $425 In-Training Non-Member: $300 : Registrants must bring a laptop to the course to view the course material. Assemblies on Clinical Problems; Allergy,Immunology and Inflammation; Behavioral Science and Health Services Research; Nursing; Pulmonary Circulation; Pulmonary Rehabilitation 8:00 a.m. - 4:00 p.m. KBHCCD Room C155 (Level 1) Target Audience This session should be broadly relevant to those who provide clinical care for patients with ILD including pulmonary fellows, general pulmonologists, ILD specialists, and advanced care nurses. Objectives At the conclusion of this session, the participant will be able to: • apply a consistent, effective strategy to ILD/IPF diagnosis • understand the range of therapeutics available for ILD and how and when to prescribe them ATS 2019 • Dallas, TX SATURDAY • MAY 18 15 SATURDAY

RkJQdWJsaXNoZXIy MTM1ODMw